[{"NetIncomeLoss_1_Q2_USD":-39935000.0,"Liabilities_0_Q2_USD":106866000.0,"Investments_0_Q2_USD":108346000.0,"StockGrantedDuringPeriodValueSharebasedCompensation_1_Q2_USD":2346000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":22.96,"GeneralAndAdministrativeExpense_2_Q2_USD":30270000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":15234000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":39174000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":21.58,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":53928000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q2_USD":40900000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-20439000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":1181471000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_2_Q2_shares":1790246.0,"AssetsCurrent_0_Q2_USD":366996000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":117546000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":39000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":22000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_2_Q2_USD":8000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q2_USD":-10000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":99800000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":108346000.0,"Assets_0_Q2_USD":425911000.0,"UnrealizedGainLossOnInvestments_1_Q2_USD":-10000.0,"ShareBasedCompensation_2_Q2_USD":11356000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":4000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":16.36,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":23208000.0,"OtherAssetsNoncurrent_0_Q2_USD":19520000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":55780000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":21.48,"InventoryRawMaterials_0_Q2_USD":607000.0,"EarningsPerShareBasic_2_Q2_USD":-1.56,"EarningsPerShareBasic_1_Q2_USD":-0.66,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":60068315.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":58643496.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":5365000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":365000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":344000.0,"AccountsReceivableNetCurrent_0_Q2_USD":45248000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":188970000.0,"CommonStockValue_0_Q2_USD":601000.0,"Revenues_1_Q2_USD":30757000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_2_Q2_USD":8100000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":5510000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":103004000.0,"CostsAndExpenses_2_Q2_USD":139210000.0,"CostsAndExpenses_1_Q2_USD":71036000.0,"IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_2_Q2_USD":1668000.0,"InventoryWorkInProcessAndRawMaterials_0_Q2_USD":6476000.0,"IncreaseDecreaseInInventories_2_Q2_USD":6476000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-91199000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-39945000.0,"Revenues_2_Q2_USD":47638000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":98200000.0,"IncreaseDecreaseInOtherCurrentLiabilities_2_Q2_USD":0.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommonStockSharesOutstanding_0_Q2_shares":60133447.0,"EarningsPerShareDiluted_2_Q2_USD":-1.56,"EarningsPerShareDiluted_1_Q2_USD":-0.66,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":8194010.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":5000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":6113000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-74726000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":58643496.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":60068315.0,"InventoryWorkInProcess_0_Q2_USD":5869000.0,"LiabilitiesCurrent_0_Q2_USD":69924000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":22166000.0,"AccountsPayableCurrent_0_Q2_USD":9818000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":17956000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":4600000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":50662000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-4404000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q2_USD":1000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":319045000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":250175.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":118000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":25634000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":39395000.0,"NetIncomeLoss_2_Q2_USD":-91207000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":188970000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":7839000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-863028000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":4957615.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":15.11,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":974000.0,"CommonStockSharesAuthorized_0_Q2_shares":125000000.0,"OperatingIncomeLoss_2_Q2_USD":-91572000.0,"OperatingIncomeLoss_1_Q2_USD":-40279000.0,"InventoryNet_0_Q2_USD":6476000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":1800000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":16565000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":20.72,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":18.35,"LiabilitiesAndStockholdersEquity_0_Q2_USD":425911000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":11356000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":6070000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":187526.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":4367000.0,"ProfitLoss_1_Q2_USD":-39935000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":258000.0,"StockholdersEquity_0_Q2_USD":319045000.0,"DebtSecuritiesAvailableForSaleAllowanceForCreditLoss_0_Q2_USD":0.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":13476000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":2693000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":108345000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-808000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":8610898.0,"ResearchAndDevelopmentExpense_2_Q2_USD":108901000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":18659000.0,"Ticker":"MGNX","CIK":"1125345","name":"MACROGENICS INC","OfficialName":"MacroGenics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"504089511.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210729"}]